共 50 条
- [31] Investigating genes and pathways that play a role in immune responses mediated by anti-CTLA-4 therapy.JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)Gao, JianjunChen, HongTang, Derek NgSharma, Padmanee
- [32] CTLA4 methylation predicts response to anti-PD-1 and anti-CTLA-4 immunotherapy in melanoma patientsJCI INSIGHT, 2018, 3 (13):Goltz, DianeGevensleben, HeidrunVogt, Timo J.Dietrich, JoernGolletz, CarstenBootz, FriedrichKristiansen, GlenLandsberg, JenniferDietrich, Dimo
- [33] MAPK/ERK SIGNALING IN GLIOMAS MODULATES INTERFERON RESPONSES, PROMOTES TUMOR-MICROGLIA CROSSTALK, AND CONFERS SUSCEPTIBILITY TO ANTI-PD-1 AND ANTI-CTLA-4 IMMUNOTHERAPYNEURO-ONCOLOGY, 2024, 26Kim, Kwang-SooZhang, JunyiDmello, CrismitaGrabis, ElenaArrieta, VictorHabashy, KarlZhao, JunfeiDuffy, JosephGould, AndrewChen, LiBalyasnikova, IrinaCanoll, PeterSims, PeterRabadan, RaulLee-Chang, CatalinaHeiland, Dieter HenrikSonabend, Adam
- [34] Expression of IFNgR on tumor cells impact response to anti-CTLA-4JOURNAL OF IMMUNOLOGY, 2015, 194Gao, JianjunShi, LewisXiong, LiangwenHe, QiumingChen, JianfengShen, De-YuSharma, Padmanee
- [35] ATG/TMG immunosuppressive effect is mediated by anti-CTLA-4 antibodiesTISSUE ANTIGENS, 2002, 59 : 142 - 142Pistillo, MPTazzari, PLBonifazi, FBandini, GKato, TMatsui, TNishioka, KConte, RFerrara, GB
- [36] Immunological Characteristics of Colitis Associated with Anti-CTLA-4 Antibody TherapyCANCER INVESTIGATION, 2017, 35 (07) : 443 - 455Bamias, GiorgosDelladetsima, IoannaPerdiki, MarinaSiakavellas, Spyros I.Goukos, DimitriosPapatheodoridis, George V.Daikos, George L.Gogas, Helen
- [37] DOSE-DEPENDENT EFFECT OF ANTI-CTLA-4 ON SURVIVAL IN SEPSISSHOCK, 2011, 36 (01): : 38 - 44Inoue, ShigeakiBo, LulongBian, JinjunUnsinger, JacquelineChang, KatherineHotchkiss, Richard S.
- [38] How Does an Anti-CTLA-4 Antibody Promote Cancer Immunity?TRENDS IN IMMUNOLOGY, 2018, 39 (12) : 953 - 956Liu, YangZheng, Pan
- [39] Induction of CTL responses by simultaneous administration of liposomal peptide vaccine with anti-CD40 and anti-CTLA-4 mAbJOURNAL OF IMMUNOLOGY, 2000, 164 (03): : 1230 - 1235Ito, DOgasawara, KIwabuchi, KInuyama, YOnoé, K
- [40] Late interferon-gamma blockade improves antitumor efficacy of anti-CTLA-4 and anti-PD-1 combination treatmentCANCER RESEARCH, 2020, 80 (16)Mok, StephenChin, ReneeAllison, James P.